High mobility group protein B1 is a predictor of poor survival in ovarian cancer

por Machado, Lee R., Moseley, Paul M., Moss, Robert, Deen, Suha, Nolan, Christopher, Spendlove, Ian, Ramage, Judith M., Chan, Stephen YT., Durrant, Lindy G.
Publicado 2017

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy

por Al-Subhi, Nouf, Ali, Reem, Abdel-Fatah, Tarek, Moseley, Paul M., Chan, Stephen Y. T., Green, Andrew R., Ellis, Ian O., Rakha, Emad A., Madhusudan, Srinivasan
Publicado 2018

DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers

por Abdel-Fatah, Tarek M.A., Arora, Arvind, Moseley, Paul M., Perry, Christina, Rakha, Emad A., Green, Andrew R., Chan, Stephen Y.T., Ellis, Ian O., Madhusudan, Srinivasan
Publicado 2015

Is There a Role for Base Excision Repair in Estrogen/Estrogen Receptor-Driven Breast Cancers?

por Abdel-Fatah, Tarek M.A., Perry, Christina, Arora, Arvind, Thompson, Nicola, Doherty, Rachel, Moseley, Paul M., Green, Andrew R., Chan, Stephen Y.T., Ellis, Ian O., Madhusudan, Srinivasan
Publicado 2014

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers

por Abdel-Fatah, Tarek M. A., Ali, Reem, Sadiq, Maaz, Moseley, Paul M., Mesquita, Katia A., Ball, Graham, Green, Andrew R., Rakha, Emad A., Chan, Stephen Y. T., Madhusudan, Srinivasan
Publicado 2019

Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression

por Kotecha, Shreeya, Lebot, Marie N., Sukkarn, Bhudsaban, Ball, Graham, Moseley, Paul M., Chan, Stephen Y., Green, Andrew R., Rakha, Emad, Ellis, Ian O., Martin, Stewart G., Storr, Sarah J.
Publicado 2019

Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts()

por Abdel-Fatah, Tarek M.A., Arora, Arvind, Alsubhi, Nouf, Agarwal, Devika, Moseley, Paul M., Perry, Christina, Doherty, Rachel, Chan, Stephen Y.T., Green, Andrew R., Rakha, Emad, Ball, Graham, Ellis, Ian O., Madhusudan, Srinivasan
Publicado 2014

Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse...

por Foulds, Gemma A., Vadakekolathu, Jayakumar, Abdel-Fatah, Tarek M. A., Nagarajan, Divya, Reeder, Stephen, Johnson, Catherine, Hood, Simon, Moseley, Paul M., Chan, Stephen Y. T., Pockley, A. Graham, Rutella, Sergio, McArdle, Stephanie E. B.
Publicado 2018

Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor–Positive Breast Cancer

por Abdel-Fatah, Tarek M. A., Ball, Graham R., Thangavelu, Pulari U., Reid, Lynne E., McCart Reed, Amy E., Saunus, Jodi M., Duijf, Pascal H. G., Simpson, Peter T., Lakhani, Sunil R., Pongor, Lorinc, Győrffy, Balázs, Moseley, Paul M., Green, Andrew R., Pockley, Alan G., Caldas, Carlos, Ellis, Ian O., Chan, Stephen Y. T.
Publicado 2020

SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment

por Abdel-Fatah, Tarek M. A., Broom, Reuben J., Lu, Jun, Moseley, Paul M., Huang, Baiqu, Li, Lili, Liu, Suling, Chen, Longxin, Ma, Runlin Z., Cao, Wenming, Wang, Xiaojia, Li, Yan, Perry, Jo K., Aleskandarany, Mohammed, Nolan, Christopher C., Rakha, Emad A., Lobie, Peter E., Chan, Stephen Y. T., Ellis, Ian O., Hwang, Le-Ann, Lane, David P., Green, Andrew R., Liu, Dong-Xu
Publicado 2019